Skip to main content
Podcasts

Reducing Major Bleeding, CVD-Associated Deaths With Edoxaban


May 05, 2020

php logoRobert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care professionals to get to know all of the available NOACs.

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top